BR9704964A - Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais - Google Patents

Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais

Info

Publication number: BR9704964A
Authority: BR; Brazil
Prior art keywords: sulbutiamine; psychomotor; psycho; treatment; pharmaceutical compositions
Prior art date: 1996-10-04

Application number

BR9704964A

Other languages

English (en)

Inventor

Helene Ollat

Laurent Perret

Ridant Alain Le

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-04

Filing date

1997-10-02

Publication date

1998-10-27

1997-10-02 Application filed by Adir filed Critical Adir

1998-10-27 Publication of BR9704964A publication Critical patent/BR9704964A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Preliminary Treatment Of Fibers (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BR9704964A 1996-10-04 1997-10-02 Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais BR9704964A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9612112A FR2754178B1 (fr)	1996-10-04	1996-10-04	Utilisation de la sulbutiamine pour l'obtention de compositions pharmaceutiques utiles dans le traitement de certains troubles psychomoteurs et psycho-intellectuels

Publications (1)

Publication Number	Publication Date
BR9704964A true BR9704964A (pt)	1998-10-27

Family

ID=9496363

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9704964A BR9704964A (pt)	1996-10-04	1997-10-02	Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais

Country Status (17)

Country	Link
US (1)	US5863925A (pt)
EP (1)	EP0834316B1 (pt)
JP (1)	JP4234218B2 (pt)
CN (1)	CN1091370C (pt)
AT (1)	ATE216884T1 (pt)
AU (1)	AU716329B2 (pt)
BR (1)	BR9704964A (pt)
CA (1)	CA2217463C (pt)
DE (1)	DE69712287T2 (pt)
DK (1)	DK0834316T3 (pt)
ES (1)	ES2176642T3 (pt)
FR (1)	FR2754178B1 (pt)
HU (1)	HU227542B1 (pt)
NO (1)	NO313684B1 (pt)
NZ (1)	NZ328915A (pt)
PT (1)	PT834316E (pt)
ZA (1)	ZA978879B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ20031902A3 (cs) *	2001-01-31	2004-07-14	Pfizer Products Inc.	Etherové deriváty užitečné jako inhibitory isozymů PDE4
NZ530158A (en) *	2002-12-20	2005-11-25	Therakos Inc	Irradiation chamber
US20070185141A1 (en) *	2006-02-09	2007-08-09	Tim Patterson	Thiamine composition for enhancement of physical and mental energy, and related method
WO2014172372A1 (en)	2013-04-15	2014-10-23	Northwestern University	Treatment for dopaminergic disorders

1996
- 1996-10-04 FR FR9612112A patent/FR2754178B1/fr not_active Expired - Fee Related
1997
- 1997-09-29 CN CN97122552A patent/CN1091370C/zh not_active Expired - Fee Related
- 1997-10-01 JP JP26831697A patent/JP4234218B2/ja not_active Expired - Fee Related
- 1997-10-02 CA CA002217463A patent/CA2217463C/fr not_active Expired - Fee Related
- 1997-10-02 NO NO19974551A patent/NO313684B1/no not_active IP Right Cessation
- 1997-10-02 BR BR9704964A patent/BR9704964A/pt not_active Application Discontinuation
- 1997-10-03 DE DE69712287T patent/DE69712287T2/de not_active Expired - Lifetime
- 1997-10-03 AT AT97402320T patent/ATE216884T1/de active
- 1997-10-03 DK DK97402320T patent/DK0834316T3/da active
- 1997-10-03 PT PT97402320T patent/PT834316E/pt unknown
- 1997-10-03 EP EP97402320A patent/EP0834316B1/fr not_active Expired - Lifetime
- 1997-10-03 ZA ZA9708879A patent/ZA978879B/xx unknown
- 1997-10-03 AU AU39928/97A patent/AU716329B2/en not_active Ceased
- 1997-10-03 HU HU9701606A patent/HU227542B1/hu not_active IP Right Cessation
- 1997-10-03 US US08/943,564 patent/US5863925A/en not_active Expired - Lifetime
- 1997-10-03 ES ES97402320T patent/ES2176642T3/es not_active Expired - Lifetime
- 1997-10-06 NZ NZ328915A patent/NZ328915A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO974551D0 (no)	1997-10-02
JP4234218B2 (ja)	2009-03-04
CN1182588A (zh)	1998-05-27
FR2754178A1 (fr)	1998-04-10
NO313684B1 (no)	2002-11-18
ZA978879B (en)	1998-04-17
FR2754178B1 (fr)	2002-08-23
US5863925A (en)	1999-01-26
HUP9701606A3 (en)	1999-07-28
DE69712287T2 (de)	2002-12-12
NZ328915A (en)	2000-08-25
JPH10130151A (ja)	1998-05-19
ATE216884T1 (de)	2002-05-15
CA2217463C (fr)	2003-04-01
ES2176642T3 (es)	2002-12-01
CN1091370C (zh)	2002-09-25
CA2217463A1 (fr)	1998-04-04
DE69712287D1 (de)	2002-06-06
AU3992897A (en)	1998-04-09
EP0834316A1 (fr)	1998-04-08
NO974551L (no)	1998-04-06
HUP9701606A2 (hu)	1998-06-29
HU9701606D0 (en)	1997-11-28
HU227542B1 (en)	2011-08-29
EP0834316B1 (fr)	2002-05-02
DK0834316T3 (da)	2002-08-05
AU716329B2 (en)	2000-02-24
PT834316E (pt)	2002-08-30

Similar Documents

Publication	Publication Date	Title
BR9403783A (pt)	1995-05-23	Uso de uma composição cosmética
IL132398A0 (en)	2001-03-19	Piperazine derivatives and their use as anti-inflammatory agents
NO20001754L (no)	2000-06-07	Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
ES2162951T3 (es)	2002-01-16	Estabilizacion de composiciones de prostaglandina.
DE69101922D1 (de)	1994-06-09	Verwendung von pyrimidin-3-oxydderivaten zur verhütung von haarausfall und deren anwendung in topischen zusammensetzungen.
PT932400E (pt)	2003-03-31	Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
FR2750047B1 (fr)	1998-12-31	Composition cosmetique ou dermatologique sous forme d'un gel aqueux de forte viscosite
ES2195000T3 (es)	2003-12-01	Composicion farmaceutica.
ES2041845T3 (es)	1993-12-01	Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos.
ES545155A0 (es)	1986-02-01	Procedimiento para la obtencion de (pirrol-1-il)-fenil-dihi-dropiridazinona
IT1240683B (it)	1993-12-17	Composizione farmaceutica contenente egf
BR9704964A (pt)	1998-10-27	Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais
ES2169942T3 (es)	2002-07-16	Uso de preparaciones topicas de trinitrato de glicerilo y lanolina para el tratamiento de la disfuncion erectil.
ITMI912466A1 (it)	1993-03-18	Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
IT1291895B1 (it)	1999-01-21	Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
AR026756A1 (es)	2003-02-26	Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos
ES2150034T3 (es)	2000-11-16	Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
SE8802323D0 (sv)	1988-06-21	8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ITMI941939A0 (it)	1994-09-23	Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
IT1282952B1 (it)	1998-04-02	Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento della costipazione
IT1282951B1 (it)	1998-04-02	Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
UA43435C2 (uk)	2001-12-17	Композиція інгредієнтів для гіркої настоянки "старовинна"
ITMI942452A0 (it)	1994-12-02	Composizione per il trattamento cosmetico delle strutture cheratiniche
IT9048240A0 (it)	1990-08-29	Uso di alfa-chetoglurato di arginina e/oppure di diarginina nella preparazione di composizioni farmaceutiche per il trattamento di deficit psicologici, immunologici e dell'apprendimento
IT1287145B1 (it)	1998-08-04	Composizioni farmaceutiche utili nel trattamento del dismetabolismo osseo

Legal Events

Date	Code	Title	Description
2002-04-30	PC	Transfer	Free format text: LES LABORATOIRES SERVIER (FR)
2003-10-14	FA10	Dismissal: dismissal - article 33 of industrial property law
2003-11-18	HKFN	Application deemed withdrawn (deleted)
2007-07-17	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2008-05-13	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO ART. 8O, ART. 11 E ART. 13 DA LPI E AOS ART. 24 E 25 DA LPI